Accelerated approval seen as triumph and roadblock for cancer drugs.
Susman
Edward
E
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval / Q000458:organization & administration*; D004354:Drug Screening Assays, Antitumor; D015507:Drugs, Investigational / Q000627:therapeutic use; D023381:Endpoint Determination; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D015507:Drugs, Investigational